Filter Results
:
(1,103)
Show Results For
-
All HBS Web
(1,103)
- People (1)
- News (306)
- Research (682)
- Events (5)
- Multimedia (15)
- Faculty Publications (396)
Show Results For
-
All HBS Web
(1,103)
- People (1)
- News (306)
- Research (682)
- Events (5)
- Multimedia (15)
- Faculty Publications (396)
- Research Summary
What Makes the Bonding Stick? A Natural Experiment Involving the U.S. Supreme Court and Cross-Listed Firms
On March 29, 2010, the U.S. Supreme Court signaled its intention to geographically limit the reach of the U.S.securities antifraud regime and thus differentially exclude U.S.-listed foreign firms from the ambit of formal U.S.antifraud enforcement. We exploit this... View Details
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (F): Appeals Court Ruling
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (F): Appeals Court Ruling." Harvard Business School Supplement 806-082, January 2006. (Revised May 2007.)
- August 2023 (Revised May 2024)
- Case
Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations
By: Satish Tadikonda and Amanda McEwen
Tadikonda, Satish, and Amanda McEwen. "Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations." Harvard Business School Case 824-018, August 2023. (Revised May 2024.)
- 11 Dec 2017
- News
Leadership Lessons from the Basketball Court
Chrissie Gorman (MBA 2012) created PowerForward with Duke basketball legend Coach K. to bring leadership and team-development lessons from sports to the business world. In this video, she explains the ground rules of team play View Details
- fall 2002
- Article
Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial." Chemical Heritage, no. 20 (fall 2002): 12–13, 28–33.
- Research Summary
Get in Line: Chapter 11 Restructuring in Crowded Bankruptcy Courts
This paper tests whether Chapter 11 restructuring outcomes are affected by time constraints in busy bankruptcy courts. On average, total bankruptcy filings rise by 32% during economic recessions, leaving bankruptcy judges with far less time per case exactly when...
View Details
- January 17, 2022
- Article
Reducing Racial Disparities in Cancer Outcomes
By: Kathy Giusti and Richard G. Hamermesh
A disproportionate number of Black patients die from cancer in the United States. A key to addressing this problem is enrolling more Black patients in clinical trials. A strategy consisting of these three parts can help accomplish this goal: 1) centralize information...
View Details
Giusti, Kathy, and Richard G. Hamermesh. "Reducing Racial Disparities in Cancer Outcomes." Harvard Business Review (website) (January 17, 2022).
- 2021
- Chapter
History on Trial: Mau Mau Reparations and the High Court of Justice
By: Jaqueline Bhabha, Caroline M. Elkins and Margareta Matache
Bhabha, Jaqueline, Caroline M. Elkins, and Margareta Matache. "History on Trial: Mau Mau Reparations and the High Court of Justice." In Time for Reparations: A Global Perspective, edited by Jaqueline Bhabha, Margareta Matache, and Caroline M. Elkins, 101–118. Philadelphia, PA: University of Pennsylvania Press, 2021.
- January 2018
- Article
The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials
By: Aaron V. Kaplan and Ariel D. Stern
The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of...
View Details
Keywords:
Health Testing and Trials;
Business and Government Relations;
Governing Rules, Regulations, and Reforms;
Information Publishing;
Medical Devices and Supplies Industry;
United States
Kaplan, Aaron V., and Ariel D. Stern. "The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials." JAMA Cardiology 3, no. 1 (January 2018): 5–6.
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
The Supreme Court has spoken, and its ruling last Friday has evoked myriad responses from across the United States—from the far right to the far left, from small businesses to giant corporations, from...
View Details
- 31 Oct 2018
- News
Dialysis Giant DaVita Defends Itself In Court And At The Polls
- Web
Statement on Supreme Court Decision | About
Statement on Supreme Court Decision Harvard University leadership, including Dean Srikant Datar, address the Harvard community after the Supreme Court delivered its decision in Students for Fair Admissions...
View Details
- 2013
- Working Paper
What Makes the Bonding Stick? A Natural Experiment Involving the U.S. Supreme Court and Cross-Listed Firms
By: Amir N. Licht, Christopher Poliquin, Jordan I. Siegel and Xi Li
On March 29, 2010, the U.S. Supreme Court signaled its intention to geographically limit the reach of the U.S. securities antifraud regime and thus differentially exclude U.S.-listed foreign firms from the ambit of formal U.S. antifraud enforcement. We use this legal...
View Details
Keywords:
Crime and Corruption;
International Finance;
Investment;
Corporate Governance;
Governing Rules, Regulations, and Reforms;
Courts and Trials;
Legal Liability;
United States
Licht, Amir N., Christopher Poliquin, Jordan I. Siegel, and Xi Li. "What Makes the Bonding Stick? A Natural Experiment Involving the U.S. Supreme Court and Cross-Listed Firms." Harvard Business School Working Paper, No. 11-072, January 2011. (Revised August 2013.)
- December 1994
- Case
Alpha-Beta Technology, Inc. (B): Trials with Betafectin
This case follows the development of a firm's first product, the public presentation of research results, and the stock market reactions. In spite of successful research, the stock price falls dramatically. Asks why this happened, how concerned the CEO should be,...
View Details
Teisberg, Elizabeth O., and Sharon L. Rossi. "Alpha-Beta Technology, Inc. (B): Trials with Betafectin." Harvard Business School Case 795-045, December 1994.
- August 1997 (Revised July 1999)
- Case
Hewlett-Packard's Santa Rosa Systems Division (A): The Trials and Tribulations of a Legacy
By: Michael Beer
Describes the process of transforming a recently formed division of Hewlett-Packard.
View Details
Beer, Michael. "Hewlett-Packard's Santa Rosa Systems Division (A): The Trials and Tribulations of a Legacy." Harvard Business School Case 498-011, August 1997. (Revised July 1999.)
- 17 Sep 2021
- Research & Ideas
The Trial of Elizabeth Holmes: Visionary, Criminal, or Both?
Former Theranos employees began testifying this week against Elizabeth Holmes, the once-celebrated biotech’s founder and CEO, in a criminal trial that has Silicon Valley worried. In opening statements last...
View Details
- January 2018
- Article
The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial
By: Leslie K. John, Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein and Kevin Volpp
Purpose: We tested the effects of employer subsidies on employee enrollment, attendance, and weight loss in a nationally-available weight management program.
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details
Keywords:
Affordable Care Act (ACA);
Subsidies;
Weight Loss;
Obesity;
Incentives;
Behavioral Economics;
Motivation and Incentives;
Behavior;
Health Disorders;
Health Care and Treatment;
Compensation and Benefits;
United States
John, Leslie K., Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein, and Kevin Volpp. "The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial." American Journal of Health Promotion 32, no. 1 (January 2018): 170–176.